Drug-induced osteoporosis with pathological fracture

OSTPOPATFRACTURE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M80.4# Cause of death: ICD-10 — M80.4# 2 out of 7 registries used, show all original rules.	576
4. Check minimum number of events None	576
5. Include endpoints None	576
6. Filter based on genotype QC (FinnGen only)	562

Control definitions (FinnGen only)

Control exclude: OSTEOPOROSIS_FRACTURE_FG

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M80
Name in latin: Osteoporosis e medicamento cum fractura pathologica

NAME	OSTPOPATFRACTURE
CONTROL_EXCLUDE	OSTEOPOROSIS_FRACTURE_FG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M804
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M804
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced osteoporosis with pathological fracture based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2573	1758	796
Only index persons	2250	1568	682
Unadjusted period prevalence (%)
Whole population	0.04	0.05	0.02
Only index persons	0.05	0.06	0.03
Median age at first event (years)
Whole population	70.33	71.59	67.62
Only index persons	70.23	71.36	67.63

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	562	396	166
Unadjusted period prevalence (%)	0.12	0.14	0.08
Median age at first event (years)	69.19	68.77	70.18

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
576: Matched controls
5760

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

+∞

307.7

576

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

19.2

267.9

264

243

M05BX04

ATC

denosumab; parenteral

19.9

265.6

252

217

318

Kela drug reimbursment

Teriparatide

561.6

227.7

212

H05AA02

ATC

teriparatide; parenteral

511.1

213.2

200

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

33.3

210.5

142

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

26.2

192.0

142

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

56.3

184.4

106

M05BA04

ATC

alendronic acid; oral

11.5

183.7

257

377

L04AX01

ATC

azathioprine; systemic

19.1

176.5

153

107

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

10.8

170.2

245

369

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

10.2

162.3

247

396

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

15.2

157.6

502

1776

L95

ICPC

Osteoporosis

14.1

142.3

146

135

L04AX03

ATC

methotrexate; systemic

9.5

141.5

215

339

M81.9

ICD-10 Finland

Osteoporosis, unspecified

12.4

135.6

153

163

H02AB06

ATC

prednisolone; systemic

11.6

116.8

504

2170

P01BA02

ATC

hydroxychloroquine; oral

8.4

115.5

188

315

L04AA06

ATC

mycophenolic acid; systemic

31.1

113.5

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

9.5

109.2

151

208

H02AB09

ATC

hydrocortisone; systemic

17.2

104.7

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

12.8

104.5

110

104

L01BA01

ATC

methotrexate; systemic

12.9

101.4

106

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

8.8

96.4

140

203

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

10.4

96.3

119

141

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.0

92.6

233

590

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

8.1

92.1

144

227

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

11.8

91.4

101

102

H02AB07

ATC

prednisone; oral

6.0

88.5

213

516

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.1

77.9

244

730

M05BA07

ATC

risedronic acid; oral

9.6

74.4

116

L88

ICPC

Rheumatoid/seropositive arthritis

9.6

73.1

113

L04AA13

ATC

[U] leflunomide

12.5

72.5

M81.4

ICD-10 Finland

Drug-induced osteoporosis

273.6

72.1

N02AA05

ATC

oxycodone; systemic

4.7

70.2

240

760

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.5

68.8

277

990

J01MA12

ATC

levofloxacin; systemic

4.6

67.8

229

716

R50.9

ICD-10 Finland

Fever, unspecified

4.9

63.8

184

505

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.6

61.4

427

2201

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

12.5

61.4

H02AB04

ATC

methylprednisolone; systemic

4.7

61.3

186

530

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.2

60.9

156

387

ZX120

NOMESCO Finland

Intravenous

5.3

60.4

147

349

A07EC01

ATC

sulfasalazine; oral, rectal

6.0

59.0

120

242

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

12.3

58.0

C03CA01

ATC

furosemide; systemic

3.9

57.4

321

1404

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.8

55.4

320

1421

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.5

55.2

101

L04AD01

ATC

ciclosporin; systemic

14.7

54.3

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

9.0

54.0

N02AX02

ATC

tramadol; systemic, rectal

3.9

53.4

382

1937

127

Kela drug reimbursment

Transplant complication

20.9

53.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.1

52.5

191

616

M05BB03

ATC

alendronic acid and colecalciferol; oral

9.6

50.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

50.6

300

1335

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.4

50.2

155

441

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

9.0

50.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.2

48.7

114

259

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

8.5

48.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.2

47.9

112

254

TPH04

NOMESCO Finland

Cathetrisation of vein

3.7

47.9

226

863

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.6

46.7

134

359

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

10.7

46.0

TGC00

NOMESCO Finland

Bronchial lavation

9.5

46.0

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.2

45.9

159

L04AB01

ATC

etanercept; parenteral

17.6

45.7

L04AA01

ATC

[U] ciclosporin

17.6

45.7

GD1AD

NOMESCO Finland

Thorax CT examination

5.8

45.2

180

M35.3

ICD-10 Finland

Polymyalgia rheumatica

6.1

44.5

156

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

8.4

43.7

SPAT1255

SPAT

Intravenous administration of medicine

5.5

43.3

195

S97

ICPC

Chronic ulcer skin

5.2

43.2

100

224

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.5

42.3

121

322

R03BB04

ATC

tiotropium bromide; inhalant

4.4

42.2

127

351

NF1AA

NOMESCO Finland

Hip X-ray examination

4.3

42.1

128

357

X59

ICD-10 Finland

Exposure to unspecified factor

3.6

41.9

189

692

N03AX16

ATC

[U] pregabalin

3.3

41.4

234

985

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.7

41.4

167

M54.5

ICD-10 Finland

Low back pain

3.2

41.0

303

1490

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

116.0

40.3

M81.8

ICD-10 Finland

Other osteoporosis

14.6

40.3

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.6

40.2

110

282

J01MA14

ATC

moxifloxacin; systemic

4.4

40.2

117

315

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

8.0

40.1

L28

ICPC

Limited function/disability (L)

3.4

40.1

201

784

J46

ICD-10 Finland

Status asthmaticus

8.8

39.9

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

15.5

39.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.7

39.1

159

542

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.2

39.0

123

351

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.9

39.0

138

428

J45.9

ICD-10 Finland

Asthma, unspecified

3.3

38.7

197

774

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

7.5

38.0

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.3

37.8

115

319

L03

ICPC

Low back symptom/complaint

3.1

37.5

248

1132

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.2

37.2

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

52.7

37.2

M01CB01

ATC

sodium aurothiomalate; parenteral

12.7

37.1

A07AA09

ATC

vancomycin; oral

14.4

36.8

A07AA02

ATC

nystatin; oral

4.8

36.7

215

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.0

36.6

330

1780

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.4

36.4

103

270

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

12.7

36.2

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.0

36.2

122

364

A46

ICD-10 Finland

Erysipelas

3.6

36.1

148

505

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

35.7

194

787

SPAT1254

SPAT

Administration of medicine

3.5

35.5

157

561

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

12.3

35.5

XG410

NOMESCO Finland

Flow-volume spirometry

6.5

35.4

103

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.5

35.3

155

552

A28

ICPC

Limited function/disability NOS

3.2

35.1

189

761

SPAT1229

SPAT

Assessment of need for aid

4.2

35.0

106

292

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.7

34.9

137

J01MA02

ATC

ciprofloxacin; systemic

2.9

34.5

311

1661

UJF32

NOMESCO Finland

Coloscopy

3.0

34.3

245

1155

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

9.7

33.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.6

33.4

135

J47

ICD-10 Finland

Bronchiectasis

8.6

33.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.1

33.1

104

294

J45.1

ICD-10 Finland

Nonallergic asthma

4.4

33.1

242

A41.9

ICD-10 Finland

Sepsis, unspecified

6.6

33.0

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

12.4

32.8

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

6.3

32.6

101

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.1

32.3

102

289

L04AB04

ATC

adalimumab; parenteral

9.9

32.1

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.1

32.0

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

12.5

31.9

ZXD05

NOMESCO Finland

Urgent procedure

2.8

31.4

240

1162

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

9.2

31.4

J01FF01

ATC

clindamycin; systemic

2.8

30.8

233

1119

X58

ICD-10 Finland

Exposure to other specified factors

3.4

30.4

130

451

L76

ICPC

Fracture: other

6.5

30.4

SPAT1216

SPAT

Assessment of functional ability

3.0

30.0

169

691

B01AB05

ATC

enoxaparin; parenteral

2.7

29.8

275

1456

J96.1

ICD-10 Finland

Chronic respiratory failure

8.6

29.8

E0000UV, ,

ATC

2.7

29.8

318

1809

NH3EA

NOMESCO Finland

Feet X-ray examination with load

8.8

29.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.0

29.2

274

S22.3

ICD-10 Finland

Fracture of rib

4.3

29.2

217

R03DA04

ATC

theophylline; systemic, rectal

4.8

29.1

160

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

4.3

29.1

222

NF3AA

NOMESCO Finland

Femur X-ray examination

7.0

29.0

J45.8

ICD-10 Finland

Mixed asthma

6.5

28.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.0

28.9

164

672

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.0

28.8

262

M05BA06

ATC

ibandronic acid; systemic

6.6

28.8

A02BC02

ATC

pantoprazole; systemic

3.4

28.7

477

3381

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

5.5

28.7

114

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.9

28.2

WZC00

NOMESCO Finland

Treatment plan or consultation

2.6

27.3

272

1479

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

10.2

27.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.4

26.8

113

387

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

7.2

26.7

R03BA05

ATC

fluticasone; inhalant

2.9

26.7

163

692

N03AX12

ATC

[U] gabapentin; oral

2.9

26.6

161

680

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

26.3

109

369

R06.0

ICD-10 Finland

Dyspnoea

2.6

26.2

233

1195

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.5

25.8

167

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

25.7

113

396

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.8

25.6

169

746

N02AJ06

ATC

codeine and paracetamol; systemic

2.5

25.5

311

1841

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

25.2

208

1025

AA1AD

NOMESCO Finland

CT of head and brain

2.5

24.9

228

1179

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.6

24.9

SPAT1262

SPAT

Handing over of treatment supplies

2.8

24.8

156

669

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.5

24.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.9

24.3

143

592

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

24.1

208

1043

XW000

NOMESCO Finland

Bone marrow biopsy

5.0

24.1

120

WZC30

NOMESCO Finland

Teaching

2.8

23.9

145

610

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.9

23.8

225

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.8

23.7

130

JN4BD

NOMESCO Finland

Extensive body CT

3.2

23.6

107

381

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.1

23.4

180

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

4.6

23.4

140

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.4

23.3

311

1893

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

7.5

23.1

JN4AD

NOMESCO Finland

Body CT examination

3.3

23.0

100

347

M13.9

ICD-10 Finland

Arthritis, unspecified

3.7

22.8

237

WX892

NOMESCO Finland

Monitored bed care

3.7

22.6

228

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

22.6

123

486

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

33.8

22.6

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.5

22.5

144

A05AA02

ATC

ursodeoxycholic acid; oral

8.7

22.4

WX002

NOMESCO Finland

Sedation and analgesia

2.6

22.3

174

828

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.1

22.1

178

Z2446

NOMESCO Finland

Social worker

3.8

21.9

208

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

21.9

329

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.6

21.9

130

R03AK08

ATC

formoterol and beclometasone; inhalant

4.7

21.7

118

Z3226

NOMESCO Finland

Physiotherapist

2.6

21.6

159

733

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.3

21.5

284

1703

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

21.4

338

2182

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

21.4

131

550

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.4

21.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.7

21.2

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.2

21.1

A06AD11

ATC

lactulose; oral

2.7

21.1

137

593

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

4.3

21.1

147

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

21.0

238

1334

NH1AD

NOMESCO Finland

Ankle and foot CT

7.7

21.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

20.9

137

596

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.6

20.9

122

WW500

NOMESCO Finland

Blood transfusion

4.6

20.8

118

R60.0

ICD-10 Finland

Localized oedema

2.9

20.8

118

476

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

20.7

315

1993

TDM10

NOMESCO Finland

Puncture of maxillary antrum

5.1

20.7

J01DB01

ATC

cefalexin; oral

3.5

20.7

516

4089

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.3

20.6

343

2252

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

20.3

181

911

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.5

20.2

155

727

UJF30

NOMESCO Finland

Ileoscopy through colon

3.0

20.1

100

374

ZX108

NOMESCO Finland

Inhalation

21.7

20.1

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

20.1

141

633

WW200

NOMESCO Finland

Immunization

6.4

20.1

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

3.8

19.9

182

H26.3

ICD-10 Finland

Drug-induced cataract

17.2

19.8

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.2

19.8

145

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.9

19.7

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.6

19.7

218

C03DA01

ATC

spironolactone; oral

2.8

19.7

116

476

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.6

19.7

141

639

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.2

19.4

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.1

19.2

148

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

5.9

19.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

19.2

100

384

A02BC05

ATC

esomeprazole; systemic

2.2

19.1

299

1892

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

6.5

19.1

N06AX21

ATC

duloxetine; oral

2.9

19.1

105

415

Z94.4

ICD-10 Finland

Liver transplant status

57.0

19.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.1

19.0

310

M80

ICD-10 Finland

Osteoporosis with pathological fracture

16.6

19.0

A07EC02

ATC

mesalazine; oral, rectal

4.1

19.0

145

N05CF01

ATC

zopiclone; oral

2.2

18.8

252

1497

R03AC12

ATC

salmeterol; inhalant

4.1

18.8

146

WX882

NOMESCO Finland

High dependency care

5.5

18.7

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.4

18.6

N30.0

ICD-10 Finland

Acute cystitis

2.6

18.6

137

628

R03BB01

ATC

ipratropium bromide; inhalant

4.2

18.6

129

TQW40

NOMESCO Finland

Remowal of suture of skin

3.4

18.6

237

R03DC03

ATC

montelukast; oral

2.6

18.5

135

615

W19

ICD-10 Finland

Unspecified fall

3.0

18.5

338

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

18.3

131

591

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.9

18.3

158

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

4.8

18.3

SPAT1211

SPAT

Application of soft bandage

3.1

18.2

306

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

5.5

18.2

TQW99

NOMESCO Finland

Other minor procedure on skin

3.8

18.1

169

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.8

18.1

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.1

18.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.9

18.0

155

ZXE00

NOMESCO Finland

One hour or less

2.2

18.0

265

1626

M54.6

ICD-10 Finland

Pain in thoracic spine

3.3

18.0

236

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.5

18.0

210

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

18.8

17.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.3

17.9

202

1114

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.2

17.9

128

R5110, ,

SPAT

3.4

17.8

227

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

15.2

17.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.3

17.7

116

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.6

17.6

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

17.6

395

SPAT1263

SPAT

Sampling

2.1

17.6

289

1846

TK800

NOMESCO Finland

Hemodialysis

7.3

17.5

S18

ICPC

Laceration/cut

2.1

17.5

320

2129

A07EA06

ATC

budesonide; oral, local oral

4.3

17.4

113

B01AA03

ATC

warfarin; systemic

2.4

17.4

150

737

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.3

17.4

C07AB07

ATC

bisoprolol; oral

2.1

17.3

349

2404

XF600

NOMESCO Finland

Bloodpressure measurement

3.4

17.3

215

R03AC02

ATC

salbutamol; inhalant

2.2

17.2

364

2552

R03AC13

ATC

formoterol; inhalant

3.6

17.2

180

M05BA01

ATC

etidronic acid; systemic

16.6

17.2

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.0

17.1

137

K83.0

ICD-10 Finland

Cholangitis

7.8

17.1

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

18.1

17.1

R60.9

ICD-10 Finland

Oedema, unspecified

3.7

17.1

171

L29

ICPC

Musculoskeletal sympt/complt other

3.0

16.9

290

JJC00

NOMESCO Finland

Allogenic transplantation of liver

65.4

16.8

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.9

16.8

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

6.9

16.7

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.7

16.7

107

456

Z3231

NOMESCO Finland

Registered nurse

2.2

16.7

200

1126

WX872

NOMESCO Finland

Intensive care

3.9

16.6

140

M48.0

ICD-10 Finland

Spinal stenosis

2.5

16.6

120

543

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

5.6

16.5

R4110

NOMESCO Finland

Physiotherapy

2.2

16.5

208

1192

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

4.2

16.3

114

TQW80

NOMESCO Finland

Local dermatologic skincare

5.5

16.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

16.2

251

A01

ICPC

Pain general/multiple sites

2.8

16.2

356

M79.6

ICD-10 Finland

Pain in limb

2.1

16.1

295

1941

L04AD02

ATC

tacrolimus; systemic

25.3

16.1

R03AC03

ATC

terbutaline; inhalant

2.6

16.1

113

503

R11

ICD-10 Finland

Nausea and vomiting

3.0

16.1

298

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

6.4

16.1

EBA10

NOMESCO Finland

Operative extraction of tooth

3.0

16.0

276

J05AB11

ATC

valaciclovir; oral

2.5

15.9

121

559

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

4.3

15.9

103

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.5

15.8

118

541

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.2

15.7

217

XKD00

NOMESCO Finland

Uroflowmetry

2.7

15.7

405

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

15.7

105

457

A04

ICPC

Weakness/tiredness general

2.5

15.6

113

510

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.8

15.5

142

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.3

15.5

203

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.2

15.5

214

EBA15

NOMESCO Finland

Extraction of multiple teeth

4.6

15.4

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

7.2

15.4

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

24.1

15.2

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.7

15.2

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.8

15.1

130

R03BA01

ATC

beclometasone; inhalant

2.5

15.1

111

504

R4120

NOMESCO Finland

Occupational therapy

3.2

15.1

217

R01AD08

ATC

fluticasone; nasal

2.1

15.0

188

1069

R52.9

ICD-10 Finland

Pain, unspecified

2.8

14.9

340

J02AC01

ATC

fluconazole; systemic

2.0

14.9

265

1711

UKC02

NOMESCO Finland

Cystoscopy

2.4

14.9

115

534

N03AX09

ATC

lamotrigine; oral

4.2

14.8

104

M05BX03

ATC

strontium ranelate; oral

19.0

14.8

R52.2

ICD-10 Finland

Other chronic pain

4.0

14.8

118

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

6.3

14.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.1

14.8

109

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.0

14.7

260

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

4.7

14.7

K08.3

ICD-10 Finland

Retained dental root

3.1

14.7

232

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.0

14.5

115

J01FA06

ATC

roxithromycin; oral

2.0

14.4

273

1796

A01AB09

ATC

miconazole; local oral

2.7

14.4

346

L02

ICPC

Back symptom/complaint

2.7

14.4

334

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.9

14.4

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

14.3

251

1609

SAA03

NOMESCO Finland

Extended examination of mouth

2.0

14.2

245

1558

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.3

14.2

B01AB04

ATC

dalteparin; parenteral

3.6

14.2

146

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.3

14.1

K50.0

ICD-10 Finland

Crohn disease of small intestine

6.9

14.1

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.3

14.1

188

N06AA09

ATC

amitriptyline; systemic

2.6

14.0

376

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.5

14.0

152

SAA04

NOMESCO Finland

Special examination of mouth

3.5

14.0

152

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

20.7

13.9

UJF92

NOMESCO Finland

Capsular endoscopy

5.5

13.8

TKC20

NOMESCO Finland

Catheterisation of bladder

3.2

13.8

201

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

15.2

13.7

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

5.6

13.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

10.4

13.6

A02BA02

ATC

ranitidine; systemic

2.1

13.5

156

854

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

13.5

266

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.7

13.5

126

K05.18

ICD-10 Finland

Chronic gingivitis

3.3

13.5

177

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.8

13.4

E000003, ,

ATC

3.9

13.4

112

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.4

13.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.8

13.3

113

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

13.2

128

653

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.8

13.1

276

R02

ICPC

Shortness of breath/dyspnoea

2.4

13.1

104

487

SPAT1234

SPAT

Support of social functional capacity

3.3

13.1

164

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.0

13.1

213

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.8

13.0

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

13.0

205

1256

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.3

13.0

165

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

11.9

12.9

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

11.9

12.9

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

10.8

12.9

R81

ICPC

Pneumonia

4.2

12.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

12.8

459

SPAT1172

SPAT

Guidance concerning hydration

5.1

12.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

12.7

157

880

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.9

12.7

228

A07DA03

ATC

loperamide; oral

4.1

12.6

ZZA00

NOMESCO Finland

Split skin graft

4.4

12.6

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.4

12.6

A41.8

ICD-10 Finland

Other specified sepsis

5.8

12.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

12.5

231

1489

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.5

12.4

133

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

12.4

278

SPAT1325

SPAT

Vaccination

1.9

12.3

238

1554

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

12.1

300

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.4

12.1

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

12.0

135

728

PAW37

NOMESCO Finland

Biopsy of temporal artery

13.8

12.0

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.2

12.0

126

662

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

12.0

201

A02BC03

ATC

lansoprazole; oral

1.9

11.9

212

1344

ZXA10

NOMESCO Finland

Bilateral

2.1

11.8

146

815

Z01.2

ICD-10 Finland

Dental examination

1.9

11.8

268

1836

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.1

11.8

49300

ICD-8 Finland

Asthma, bronchiale

4.9

11.8

R03BA02

ATC

budesonide; inhalant

2.1

11.8

133

719

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.5

11.7

362

A08

ICPC

Swelling

3.0

11.7

198

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

66.3

11.6

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

66.3

11.6

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

5.4

11.6

N02BF01

ATC

gabapentin; oral

2.6

11.6

294

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

9.5

11.6

ZXA00

NOMESCO Finland

Right side

1.9

11.6

200

1254

S92.3

ICD-10 Finland

Fracture of metatarsal bone

3.9

11.6

NHQ40

NOMESCO Finland

Amputation of toe

5.9

11.6

K02.1

ICD-10 Finland

Caries of dentine

1.8

11.5

330

2423

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.7

11.5

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.0

11.5

N02AC04

ATC

dextropropoxyphene; oral

3.6

11.5

110

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.4

11.5

130

N05BA04

ATC

oxazepam; oral

1.9

11.4

177

1070

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.4

11.4

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.1

11.4

133

727

S20.2

ICD-10 Finland

Contusion of thorax

3.4

11.3

126

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

11.3

225

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.7

11.3

R03DC01

ATC

zafirlukast; oral

4.9

11.3

WX725

NOMESCO Finland

Noninvasive ventilation

3.1

11.3

163

M70.2

ICD-10 Finland

Olecranon bursitis

4.2

11.3

Z2221

NOMESCO Finland

Medical doctor

1.9

11.3

176

1066

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

11.2

114

591

K50.9

ICD-10 Finland

Crohn disease, unspecified

8.3

11.2

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.0

11.2

186

SAA02

NOMESCO Finland

Basic examination of mouth

1.9

11.1

375

2882

5BA08, ,

NOMESCO Finland

11.5

11.1

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.2

11.1

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

4.2

11.1

WX212

NOMESCO Finland

Femoral plexus blockade

4.6

11.1

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

5.0

11.0

A02BC01

ATC

omeprazole; systemic

1.9

11.0

190

1188

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

11.0

102

509

SPAT1167

SPAT

Insertion of urinary catheter

4.0

11.0

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.4

10.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.4

10.9

381

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

28.6

10.8

XG466

NOMESCO Finland

Sleep oxymetry

3.9

10.7

H25.8

ICD-10 Finland

Other senile cataract

2.3

10.7

452

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

61.2

10.7

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.2

10.6

B01AB10

ATC

tinzaparin; parenteral

2.4

10.6

372

K50.1

ICD-10 Finland

Crohn disease of large intestine

9.4

10.6

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.9

10.6

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.2

10.5

137

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

10.5

420

R53

ICD-10 Finland

Malaise and fatigue

1.9

10.5

163

981

L86

ICPC

Back syndrome with radiating pain

2.9

10.5

193

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

10.4

159

951

M54

ICD-10 Finland

Dorsalgia

2.3

10.4

401

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

12.3

10.4

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

16.4

10.4

J20

ICD-10 Finland

Acute bronchitis

2.4

10.4

369

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

10.3

261

1827

M25.5

ICD-10 Finland

Pain in joint

1.8

10.3

211

1387

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.1

10.3

150

WZA90

NOMESCO Finland

Other medical or dental certificate

1.9

10.3

154

916

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

10.2

408

3261

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.3

10.2

398

WX213

NOMESCO Finland

Lower leg blockade

13.4

10.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.8

10.2

190

K03.66

ICD-10 Finland

Tooth plaque

2.8

10.1

208

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

8.7

10.1

A11CC03

ATC

alfacalcidol; systemic

4.9

10.1

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.7

10.1

L17

ICPC

Foot/toe symptom/complaint

1.8

10.1

196

1266

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.7

10.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

10.0

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

10.0

105

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

4.3

10.0

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

7.8

10.0

H26.4

ICD-10 Finland

After-cataract

2.2

9.9

430

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

9.9

105

551

S72.2

ICD-10 Finland

Subtrochanteric fracture

12.5

9.9

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

9.9

TAB00

NOMESCO Finland

Lumbar puncture

3.2

9.9

132

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

10.9

9.8

J45

ICD-10 Finland

Asthma

2.4

9.8

338

R06AE07

ATC

cetirizine; oral

1.8

9.7

264

1877

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

56.0

9.7

NA2AD

NOMESCO Finland

Thoracic spine CT examination

11.6

9.6

S72.0

ICD-10 Finland

Fracture of neck of femur

3.2

9.6

129

ZX140

NOMESCO Finland

Intra articular

10.3

9.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.9

9.6

162

J01FA09

ATC

clarithromycin; systemic

1.8

9.6

197

1291

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

15.4

9.6

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.8

9.5

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

9.5

119

663

N02BE01

ATC

paracetamol; systemic, rectal

2.6

9.5

531

4704

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

9.5

241

1677

J01AA02

ATC

doxycycline; systemic

2.0

9.5

469

3959

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

9.4

222

S22.4

ICD-10 Finland

Multiple fractures of ribs

5.3

9.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

9.4

139

820

N06AX16

ATC

venlafaxine; oral

2.1

9.4

475

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

22.1

9.4

P01AB01

ATC

metronidazole; oral, rectal

1.7

9.4

257

1826

XQ800

NOMESCO Finland

Prick test

2.6

9.3

223

WX320

NOMESCO Finland

Spinalanesthesy

1.8

9.3

168

1055

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

9.3

121

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

9.3

218

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.7

9.3

200

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.7

9.3

206

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

9.2

102

543

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

9.2

171

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.2

9.2

116

J01FA10

ATC

azithromycin; systemic

1.7

9.2

334

2559

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.5

9.2

256

A06AC51

ATC

ispaghula, combinations; oral

2.9

9.2

166

E000006, ,

ATC

2.5

9.1

238

A07EA02

ATC

hydrocortisone; rectal

4.7

9.1

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.9

9.1

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

9.1

117

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.2

9.1

X57

ICD-10 Finland

Unspecified privation

4.3

9.0

J01CA04

ATC

amoxicillin; systemic

2.0

9.0

469

3982

B01AF02

ATC

apixaban; oral

2.1

8.9

513

RS220, ,

NOMESCO Finland

8.1

8.9

L01BB02

ATC

mercaptopurine; oral

8.1

8.9

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.0

8.9

L03.9

ICD-10 Finland

Cellulitis, unspecified

5.0

8.9

R03AK11

ATC

formoterol and fluticasone; inhalant

3.9

8.9

S72.3

ICD-10 Finland

Fracture of shaft of femur

9.7

8.8

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.7

8.8

L84

ICD-10 Finland

Corns and callosities

3.2

8.8

114

K51.5

ICD-10 Finland

Left sided colitis

4.2

8.8

M54.8

ICD-10 Finland

Other dorsalgia

3.3

8.8

109

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.9

8.8

147

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

8.8

281

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

8.8

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

3.5

8.7

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

6.8

8.7

B80

ICPC

Iron deficiency anaemia

4.4

8.7

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

7.8

8.7

S52.0

ICD-10 Finland

Fracture of upper end of ulna

4.5

8.7

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.7

8.6

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.9

8.6

154

WX730

NOMESCO Finland

Conventional respirator

8.4

8.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

8.6

283

B02.9

ICD-10 Finland

Zoster without complication

2.5

8.6

232

RD210, ,

NOMESCO Finland

7.1

8.6

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

10.2

8.6

R28

ICPC

Limited function/disability (R)

6.6

8.6

WVA20, ,

SPAT

3.8

8.5

H26.02

ICD-10 Finland

Presenil cataract

3.8

8.5

QDB10, ,

SPAT

4.3

8.5

D07AC13

ATC

mometasone; topical

1.8

8.5

179

1173

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

8.5

307

2329

SFA10

NOMESCO Finland

One-surface restoration

1.7

8.5

305

2310

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

28.0

8.5

L04AA17

ATC

[U] adalimumab

28.0

8.5

SPAT1301

SPAT

No procedures

1.7

8.5

204

1388

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.6

8.5

J05AB01

ATC

aciclovir; systemic

1.8

8.5

147

910

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

8.4

236

1673

JJ5AT, ,

NOMESCO Finland

91.3

8.4

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.4

8.4

260

ZZH31

NOMESCO Finland

Bone allograft, small pieces

8.0

8.4

R4110, ,

SPAT

2.3

8.4

326

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.1

8.4

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

13.0

8.4

R05

ICD-10 Finland

Cough

1.8

8.4

141

864

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

8.7

8.4

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

8.7

8.4

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.6

8.3

J01FA15

ATC

telithromycin; oral

2.2

8.3

334

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

8.3

294

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.9

8.3

R4180

NOMESCO Finland

Podiatric therapy

7.2

8.3

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

8.3

164

1055

K59.0

ICD-10 Finland

Constipation

2.6

8.2

206

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.1

8.2

119

Z50.1

ICD-10 Finland

Other physical therapy

2.7

8.2

182

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

3.3

8.2

S81.0

ICD-10 Finland

Open wound of knee

4.6

8.2

A06AH03

ATC

naloxegol; oral

4.9

8.2

A02BA03

ATC

famotidine; systemic

3.0

8.2

125

ZXA05

NOMESCO Finland

Left side

1.8

8.1

172

1127

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.6

8.1

189

Z71.8

ICD-10 Finland

Other specified counselling

1.7

8.1

180

1195

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

8.1

386

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

17.5

8.1

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

33.9

8.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

8.1

516

R96

ICPC

Asthma

2.2

8.1

359

K50.8

ICD-10 Finland

Other Crohn disease

6.4

8.1

WZA10

NOMESCO Finland

Extensive medical or dental certificate

6.4

8.1

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

10.2

8.1

L74

ICPC

Fracture: hand/foot bone

4.2

8.1

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

22.4

8.0

WZA00

NOMESCO Finland

Concise certificate

2.6

8.0

184

R4190

NOMESCO Finland

Nutritional therapy

3.5

8.0

W10

ICD-10 Finland

Fall on and from stairs and steps

2.8

8.0

149

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

8.0

236

1692

A10AC01

ATC

insulin (human); parenteral

2.5

8.0

222

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.7

7.9

M81.5

ICD-10 Finland

Idiopathic osteoporosis

7.9

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

13.3

7.9

M01AH01

ATC

celecoxib; oral

1.8

7.9

126

758

N06AX11

ATC

mirtazapine; oral

1.7

7.9

215

1509

R01AD09

ATC

mometasone; nasal

1.6

7.8

264

1954

J01DC02

ATC

cefuroxime; systemic

2.8

7.8

145

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

7.8

336

WX204

NOMESCO Finland

Axillary plexus blockaced

3.2

7.8

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

4.3

7.8

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

7.8

435

C01CA24

ATC

epinephrine; parenteral

2.6

7.8

181

C10AC01

ATC

colestyramine; oral

3.6

7.8

SPAT1260

SPAT

Consultation of another employee

1.9

7.8

117

691

SFA30

NOMESCO Finland

Three-surface restoration

1.7

7.8

246

1792

L04AA24

ATC

abatacept; parenteral

15.3

7.7

L99

ICPC

Musculoskeletal disease other

4.4

7.7

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

45.6

7.7

SCA02

NOMESCO Finland

Preventive oral health care

2.3

7.7

284

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

7.7

135

R06AX22

ATC

ebastine; oral

1.9

7.7

109

631

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.7

7.7

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

7.7

L75

ICPC

Fracture: femur

6.8

7.6

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.5

7.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

7.6

175

1171

TKC22

NOMESCO Finland

Catheterisation instruction

4.2

7.6

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

25.4

7.6

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

7.6

148

945

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

7.6

158

1028

M06

ICD-10 Finland

Other rheumatoid arthritis

9.0

7.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

7.6

196

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.2

7.5

348

R03BA08

ATC

ciclesonide; inhalant

2.2

7.5

294

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

4.5

7.5

L50.8

ICD-10 Finland

Other urticaria

4.5

7.5

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

7.4

115

105

Kela drug reimbursment

Adrenal cortical hypofunction

81.1

7.4

N03AX14

ATC

levetiracetam; systemic

3.8

7.4

U07

ICPC

Urine symptom/complaint other

2.3

7.4

262

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

7.4

243

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

7.4

184

1257

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

11.1

7.3

NDG30

NOMESCO Finland

Fusion of wrist, total

11.1

7.3

H53.4

ICD-10 Finland

Visual field defects

4.2

7.3

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

7.3

218

K13.78

ICD-10 Finland

Other change in the oral mucosa

3.9

7.3

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

+∞

7.3

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

7.3

RS221, ,

NOMESCO Finland

5.9

7.3

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.6

7.3

175

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

16.0

7.2

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.2

7.2

D68.8

ICD-10 Finland

Other specified coagulation defects

7.4

7.2

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.6

7.2

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

7.2

265

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.0

7.2

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.6

7.2

R1250

NOMESCO Finland

Evaluation of functional capability

3.6

7.2

J01EA01

ATC

trimethoprim; systemic

1.7

7.2

178

1211

XCK00

NOMESCO Finland

Perimetry

2.4

7.2

207

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.5

7.2

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

7.2

123

C08DA01

ATC

verapamil; systemic

2.7

7.2

152

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

30.4

7.2

J04AB02

ATC

rifampicin; systemic

6.7

7.2

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.5

7.1

189

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

7.1

134

845

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.1

7.1

WX202

NOMESCO Finland

Supraclavicular plexus blockade

6.2

7.1

J01CF05

ATC

flucloxacillin; systemic

2.5

7.1

183

S19

ICPC

Skin injury other

3.0

7.1

107

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.7

7.1

141

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

12.2

7.1

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.7

7.1

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

7.1

115

694

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.2

7.1

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.9

7.1

555

JF1AD

NOMESCO Finland

Small bowel CT

10.2

7.1

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

4.3

7.1

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

7.0

145

938

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

7.1

7.0

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.1

7.0

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.0

7.0

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

7.0

366

A03

ICPC

Fever

1.9

6.9

505

NB1AD

NOMESCO Finland

Shoulder CT examination

4.1

6.9

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

6.9

125

778

K99

ICPC

Cardiovascular disease other

3.6

6.9

JAH00

NOMESCO Finland

Laparotomy

3.3

6.9

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

14.0

6.9

ZX112

NOMESCO Finland

Subcutaneous

3.5

6.9

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.3

6.9

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

6.9

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.8

6.9

126

R33

ICD-10 Finland

Retention of urine

2.4

6.9

218

C08CA05

ATC

nifedipine; systemic

2.4

6.9

199

A03FA02

ATC

cisapride; oral, rectal

2.2

6.8

278

EB1WA, ,

NOMESCO Finland

11.1

6.8

R06.2

ICD-10 Finland

Wheezing

2.8

6.8

121

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

6.2

6.8

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.8

6.8

M04AA01

ATC

allopurinol; systemic

2.0

6.8

449

SPAT1125

SPAT

Stoma care and guidance

4.3

6.8

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.5

6.8

181

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

40.5

6.8

M30.0

ICD-10 Finland

Polyarteritis nodosa

40.5

6.8

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

40.5

6.8

E23.03

ICD-10 Finland

Lack of ACTH

16.9

6.8

L01AA01

ATC

cyclophosphamide; systemic

16.9

6.8

I50.0

ICD-10 Finland

Congestive heart failure

2.2

6.8

259

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

6.7

116

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

7.3

6.7

J01DA01

ATC

[U] cefalexin

1.6

6.7

359

2929

N05BA01

ATC

diazepam; systemic, rectal

1.9

6.7

518

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

6.7

385

207

Kela drug reimbursment

Chronic arrhythmias

1.8

6.7

110

665

R35

ICD-10 Finland

Polyuria

2.4

6.7

214

R5130, ,

SPAT

22.8

6.7

I77.6

ICD-10 Finland

Arteritis, unspecified

22.8

6.7

D68.9

ICD-10 Finland

Coagulation defect, unspecified

22.8

6.7

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

22.8

6.7

E000001, ,

ATC

1.8

6.7

120

746

SFA20

NOMESCO Finland

Two-surface restoration

1.6

6.7

312

2467

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

6.7

408

XF640, ,

NOMESCO Finland

3.3

6.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.4

6.6

202

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.0

6.6

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

6.6

248

-1, ,

NOMESCO Finland

1.6

6.6

181

1260

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

12.4

6.6

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.2

6.6

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

8.8

6.6

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

8.8

6.6

J01DA06

ATC

[U] cefuroxime

1.9

6.6

545

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

10.2

6.6

H20.1

ICD-10 Finland

Chronic iridocyclitis

7.0

6.5

M01AB55

ATC

diclofenac, combinations; oral

2.2

6.5

263

SPAT1210

SPAT

Application of cast or individual aid

2.7

6.5

130

A29

ICPC

General symptom/complaint other

1.9

6.5

501

R4130

NOMESCO Finland

Speech therapy

3.6

6.5

L84

ICPC

Back syndrome without radiat pain

2.6

6.5

148

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

6.5

120

752

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

7.5

6.4

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

7.5

6.4

B37.7

ICD-10 Finland

Candidal sepsis

70.6

6.4

M32

ICD-10 Finland

Systemic lupus erythematosus

70.6

6.4

S01EE01

ATC

latanoprost; ophthalmic

2.3

6.4

231

R01AD05

ATC

budesonide; nasal

2.2

6.4

251

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

6.4

159

1078

JN4CD

NOMESCO Finland

Very extensive body CT

2.8

6.4

114

D09

ICPC

Nausea

2.8

6.4

114

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.8

6.4

114

M01CB03

ATC

auranofin; oral

8.3

6.4

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

8.3

6.4

G35

ICD-10 Finland

Multiple sclerosis

6.1

6.3

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

11.2

6.3

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

11.2

6.3

H02AB08

ATC

triamcinolone; systemic

11.2

6.3

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

6.3

294

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.2

6.3

253

R63.4

ICD-10 Finland

Abnormal weight loss

2.8

6.3

109

3AC01, ,

NOMESCO Finland

9.4

6.3

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

6.3

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

18.3

6.3

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

18.3

6.3

L04AA11

ATC

[U] etanercept

18.3

6.3

R51.80

ICD-10 Finland

Headache

1.8

6.3

545

A02BX02

ATC

sucralfate; oral

2.7

6.3

121

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

6.3

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

+∞

6.3

XF404

NOMESCO Finland

Ambulatory ECG

2.1

6.3

316

D07AC01

ATC

betamethasone; topical

1.6

6.3

212

1550

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

7.1

6.2

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

7.1

6.2

NDL52

NOMESCO Finland

Tenosynovectomy of hand

7.1

6.2

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.7

6.2

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

6.2

177

1240

SPAT1310

SPAT

Counselling related to known health issue

1.6

6.2

191

1363

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

27.0

6.2

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.7

6.2

133

E000002, ,

ATC

2.1

6.2

331

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

4.0

6.2

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.4

6.2

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.5

6.2

M01AH02

ATC

rofecoxib; oral

1.8

6.2

547

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.9

6.2

UJD02

NOMESCO Finland

Gastroscopy

2.5

6.2

152

WX199

NOMESCO Finland

Other local analgesia

3.0

6.1

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.2

6.1

S41.1

ICD-10 Finland

Open wound of upper arm

12.7

6.1

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

12.7

6.1

M35.1

ICD-10 Finland

Other overlap syndromes

12.7

6.1

N86

ICPC

Multiple sclerosis

12.7

6.1

WX290

NOMESCO Finland

Other blockage of nerve

1.6

6.1

228

1703

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

8.7

6.1

1XC02, ,

NOMESCO Finland

8.7

6.1

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

6.8

6.1

SXC03

NOMESCO Finland

Other oral or dental procedure

6.8

6.1

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.6

6.1

135

SPAT1104

SPAT

Monitoring of emergency patient

2.3

6.1

204

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

10.2

6.1

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.4

6.1

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

6.1

6.0

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.1

6.0

S70

ICPC

Herpes zoster

3.1

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003458) Phosphate [Moles/volume] in Serum or Plasma

266

641

6.85

114.74

6.9

4.9

1.04

mmol/l

0.12

245

577

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

494

2138

10.21

111.82

5.2

2.3

87.56

79.34

nmol/l

8.65

468

1874

(3020630) Protein [Mass/volume] in Serum or Plasma

217

449

7.15

108.67

2.0

3.0

63.76

66.73

g/l

5.20

187

401

(3004588) Protein electrophoresis panel - Serum or Plasma

203

409

7.12

103.94

1.7

2.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

195

380

7.25

103.10

5.0

3.0

9.16

10.42

g/l

2.49

189

348

(40760892) CBC W Ordered Manual Differential panel - Blood

495

2256

9.49

102.27

19.8

6.4

—

(3022096) Basophils/100 leukocytes in Blood

482

2196

8.32

97.72

18.4

5.9

0.61

0.68

2.26

466

2033

(3036481) Cortisol [Moles/volume] in Serum or Plasma

208

456

6.57

97.12

3.1

2.0

270.40

375.54

nmol/l

6.40

198

416

(3019069) Monocytes/100 leukocytes in Blood

489

2275

8.61

96.31

19.4

6.2

8.60

8.65

0.12

474

2117

(3006504) Eosinophils/100 leukocytes in Blood

486

2264

8.34

95.04

18.5

5.9

2.29

2.82

6.67

469

2101

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

520

2594

11.33

94.15

15.8

6.3

1.22

mmol/l

0.02

438

2208

(3001604) Monocytes [#/volume] in Blood

501

2423

9.20

93.31

17.5

5.8

0.63

0.58

e9/l

5.81

474

2087

(3018010) Neutrophils/100 leukocytes in Blood

486

2288

8.19

93.13

17.5

5.8

62.90

57.33

17.54

472

2130

(3002030) Lymphocytes/100 leukocytes in Blood

489

2318

8.35

92.90

19.0

6.1

22.83

27.60

17.60

473

2158

(3006315) Basophils [#/volume] in Blood

501

2432

9.14

92.63

17.6

5.8

0.04

e9/l

0.05

473

2099

(3019198) Lymphocytes [#/volume] in Blood

503

2473

9.16

90.98

17.8

5.9

1.68

1.91

e9/l

2.12

481

2185

(3013115) Eosinophils [#/volume] in Blood

507

2513

9.49

90.85

18.4

6.1

0.16

0.19

e9/l

3.13

478

2197

(3028026) IgM [Mass/volume] in Serum or Plasma

159

307

6.77

83.47

2.5

1.9

1.09

1.23

g/l

0.51

150

278

(3002179) Metamyelocytes/100 leukocytes in Blood

174

380

6.13

80.18

6.9

4.1

0.59

0.58

0.02

128

(3023368) Bacteria identified in Blood by Culture

346

1350

4.91

78.81

8.5

4.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

213

565

5.40

78.76

4.7

4.0

256.55

252.18

u/l

0.10

198

529

(3042936) Bacteria identified in Isolate by Culture

242

716

5.10

78.41

3.4

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

519

2840

9.36

77.00

22.8

9.3

4.92

4.07

e9/l

11.88

499

2485

(3017181) Myelocytes/100 leukocytes in Blood

181

427

5.72

76.33

7.1

4.1

0.87

0.98

0.27

160

(3021440) Promyelocytes/100 leukocytes in Blood

172

395

5.78

74.60

7.2

4.3

0.07

0.13

0.62

127

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

470

2402

6.20

74.04

14.4

5.5

1.22

mmol/l

0.11

450

2174

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

255

828

4.73

72.61

3.1

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

172

424

5.36

68.32

3.5

3.6

77.69

80.54

ng/l

0.18

147

371

(3025159) Blasts/100 leukocytes in Blood

161

375

5.57

68.24

7.2

4.4

0.03

0.90

0.55

108

(3027945) Reticulocytes/100 erythrocytes in Blood

205

594

4.81

66.77

3.6

2.7

2.21

1.84

1.58

182

527

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

159

374

5.49

66.52

2.6

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

109

178

7.32

66.46

2.0

4.0

28.91

28.16

mg/l

0.07

143

(3034860) Kappa light chains.free [Mass/volume] in Serum

109

178

7.32

66.46

2.0

4.0

78.26

86.54

mg/l

0.05

143

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

108

175

7.36

66.32

2.0

3.9

1.16

2.10

ratio

0.44

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

311

1274

4.13

62.54

3.7

2.3

3.88

3.25

mg/l

3.20

278

1085

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

110

200

6.56

60.25

2.7

1.7

1.86

3.36

ug/l

0.46

174

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

102

173

6.95

59.77

2.1

1.5

132.50

126.67

titre

—

(3023520) Reticulocytes [#/volume] in Blood

168

452

4.84

59.33

4.1

2.6

76.54

72.31

e9/l

0.67

131

353

(3024561) Albumin [Mass/volume] in Serum or Plasma

431

2281

4.53

58.63

10.1

4.3

33.27

35.40

g/l

11.73

408

2123

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

155

7.05

56.46

2.6

1.4

0.23

g/l

0.03

146

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

9.58

56.21

10.1

5.3

337.36

510.45

iu/ml

0.21

(3020779) Urea [Moles/volume] in Serum or Plasma

154

402

4.86

56.21

12.5

6.2

10.67

9.43

mmol/l

0.69

148

380

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

134

314

5.26

55.62

6.9

3.5

2.42

1.93

mmol/l

0.75

110

241

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

210

708

4.09

54.47

3.5

2.2

19.69

22.21

1.31

182

603

(3009343) pH of Capillary blood

135

327

5.09

53.78

7.1

3.6

7.43

7.40

1.31

(3007164) IgA [Mass/volume] in Serum or Plasma

245

929

3.85

53.43

2.4

1.6

2.63

2.48

g/l

0.22

185

539

(3024980) IgG subclass 4 [Mass/volume] in Serum

10.86

53.36

2.2

2.1

0.75

0.98

g/l

0.34

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

9.27

53.34

2.2

2.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

214

742

4.00

53.16

3.5

2.2

2.25

2.33

g/l

1.17

200

681

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

148

6.93

52.92

1.9

1.5

0.20

0.11

iu/ml

0.27

(3012095) Magnesium [Moles/volume] in Serum or Plasma

223

798

3.93

52.88

6.9

3.2

0.80

0.81

mmol/l

0.81

209

739

(40760888) Immunoglobulin light chains.free panel - Serum

133

7.22

52.28

2.0

4.5

—

(3018418) pH of Serum or Plasma

334

1567

3.69

52.27

8.3

3.7

7.40

0.15

110

292

(3037522) Nuclear Ab [Titer] in Serum

195

648

4.04

51.22

1.8

1.3

811.03

488.38

titre

1.18

148

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

8.52

51.22

6.3

4.1

60.44

59.40

0.22

(4062490) Immunoglobulin typing, IgG

14.53

50.77

2.0

1.3

—

(3023419) Bacteria identified in Sputum by Culture

9.91

50.74

3.7

3.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

222

812

3.82

50.64

3.6

2.2

10.63

12.66

umol/l

3.08

209

743

(3030905) Polymorphonuclear cells [#/volume] in Blood

8.53

49.89

6.0

3.6

4.36

4.61

e9/l

0.29

(3007853) Bacteria identified in Skin by Aerobe culture

178

566

4.10

49.57

3.1

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

14.27

48.17

1.9

1.3

2.23

2.59

g/l

0.48

(3024139) IgG subclass 3 [Mass/volume] in Serum

14.27

48.17

1.9

1.3

0.37

0.41

g/l

0.20

(3027135) IgG subclass 1 [Mass/volume] in Serum

14.27

48.17

1.9

1.3

6.67

7.77

g/l

0.40

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

16.10

48.12

2.3

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

106

235

5.30

46.46

1.9

2.0

1.69

1.60

g/l

0.32

204

(3026782) Osmolality of Urine

247

1027

3.46

45.34

4.8

2.9

489.02

527.79

mosm/kgh2o

2.37

221

881

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

13.15

44.91

2.1

1.6

—

(3037756) Immunofixation for Serum or Plasma

128

6.59

43.25

1.4

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

7.40

42.94

1.7

4.19

4.77

mmol/24h

0.64

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

140

6.29

42.77

2.8

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

172

586

3.76

42.68

2.6

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

347

1819

3.28

42.48

4.2

3.4

2.33

2.36

mmol/l

3.26

307

1581

(3022217) INR in Platelet poor plasma by Coagulation assay

418

2454

3.56

42.18

27.7

15.2

1.32

1.26

inr

0.61

135

693

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

444

2709

3.79

42.05

14.0

5.9

11.37

11.11

umol/l

0.10

430

2561

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

152

5.95

41.34

3.5

2.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

117

6.67

41.14

2.0

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

343

1812

3.21

40.94

6.7

3.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

7.71

40.14

2.0

1.7

—

(3026008) Bacteria identified in Urine by Culture

330

1730

3.12

39.45

5.5

3.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

243

1073

3.19

39.26

1.5

1.3

0.82

1.48

u/ml

1.07

270

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

110

6.65

38.84

2.1

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

4.98

37.97

1.7

2.4

3.14

3.10

g/l

0.10

185

(3031040) Bacteria [#/volume] in Urine by Automated count

494

3338

4.37

37.76

10.1

4.7

2800.83

4368.02

e6/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

165

588

3.53

37.74

2.7

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

148

5.68

37.12

1.4

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

4.78

37.08

1.7

2.3

3.70

3.59

g/l

0.28

203

(3037467) Urinalysis macro (dipstick) panel - Urine

499

3417

4.44

36.88

10.9

4.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

4.75

36.88

1.7

2.3

7.73

7.66

g/l

0.13

203

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

4.75

36.88

1.7

2.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

539

3909

6.90

36.88

24.1

7.3

77.93

79.33

u/l

0.31

529

3636

(3000850) Epithelial cells [#/volume] in Urine

237

1068

3.07

36.43

4.9

2.5

5.77

5.64

e6/l

0.05

224

966

(3001122) Ferritin [Mass/volume] in Serum or Plasma

356

2012

3.01

36.04

4.7

2.7

140.01

121.51

ug/l

0.64

336

1820

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

308

1611

2.96

35.97

4.0

2.3

55.10

60.98

u/l

0.86

289

1473

(3013707) Erythrocyte sedimentation rate by Westergren method

519

3708

5.04

34.84

15.2

4.3

18.65

13.21

mm/h

10.12

507

3393

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.94

34.78

1.9

1.5

—

(3037121) Protein [Mass/volume] in Urine

174

5.10

34.51

3.0

3.2

0.34

0.18

g/l

0.72

(3042631) Mycobacterium sp identified in Specimen

7.90

34.43

3.1

2.7

—

(3002582) Erythrocytes [#/volume] in Urine

291

1506

2.88

34.18

6.5

3.2

29.59

95.18

e6/l

0.83

252

1164

(1616796) Gas panel - Central venous blood

6.63

33.32

5.0

3.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

7.56

33.14

1.9

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

4.59

33.03

1.5

2.3

9.13

10.28

g/l

1.07

190

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

148

5.33

32.99

6.6

2.5

0.32

0.41

u/ml

1.03

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

185

4.86

32.95

2.2

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

192

4.75

32.36

1.7

2.7

0.25

0.70

g/l

1.20

167

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

135

463

3.50

32.34

1.8

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

7.55

31.82

1.7

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

294

1574

2.77

31.69

3.5

2.1

101.46

207.44

u/l

5.11

276

1478

(3000494) Fungus identified in Specimen by Culture

160

617

3.21

31.61

2.4

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

445

2959

3.22

31.59

12.3

4.5

6.38

6.69

mmol/l

3.64

435

2788

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

138

490

3.39

31.20

3.7

2.2

0.21

g/l

0.07

129

463

(3018095) Leukocytes [#/volume] in Urine

314

1748

2.75

31.18

7.7

3.8

66.11

107.14

e6/l

0.84

257

1266

(3030467) Casts [#/volume] in Urine by Automated count

271

1402

2.76

31.09

6.4

3.1

0.40

0.47

e6/l

0.28

236

1064

(3026493) Urate [Moles/volume] in Serum or Plasma

255

1283

2.77

30.84

4.4

2.6

5564.10

7556.15

umol/l

0.25

225

1087

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

6.55

30.70

1.4

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

103

307

3.87

30.32

2.1

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

126

431

3.46

30.15

1.8

1.4

—

(3022313) Gas panel - Capillary blood

254

4.12

30.12

8.3

3.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

141

523

3.25

29.55

2.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

6.83

29.05

1.8

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

7.60

28.77

1.9

1.7

62.93

65.21

0.13

(3019309) Folate [Moles/volume] in Red Blood Cells

219

1049

2.75

28.76

2.1

1.8

1234.41

1233.93

nmol/l

0.00

171

761

(3044640) Blood type and Crossmatch panel - Blood

289

1590

2.64

28.68

4.6

2.3

—

(3044927) Protein electrophoresis panel - Urine

6.99

28.50

1.2

1.1

—

(3019225) pH of Specimen

144

552

3.14

28.45

10.6

4.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

294

1638

2.62

28.33

5.7

3.1

1717.54

1210.19

ng/l

1.77

263

1388

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

6.64

28.32

1.9

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

6.64

28.32

1.9

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

5.58

27.97

1.9

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

5.85

27.94

3.8

2.5

14.62

15.78

1.07

(36304419) Bacteria [Presence] in Urine

257

1357

2.61

27.47

6.4

3.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

196

4.31

27.16

3.5

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

183

4.42

27.06

3.2

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

182

4.38

26.39

1.6

2.2

35.21

37.20

g/l

1.74

158

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

306

3.61

26.08

2.3

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

142

4.77

25.68

2.0

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

279

3.69

25.51

1.5

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

232

1205

2.55

25.18

4.3

2.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

137

4.77

24.93

3.3

1.9

9.10

12.69

mg/l

2.24

127

(3021960) Folate [Moles/volume] in Serum or Plasma

241

1281

2.52

24.82

1.8

1.6

22.70

21.51

nmol/l

0.48

204

1062

(3008757) Leukocyte morphology finding [Identifier] in Blood

6.90

24.58

3.3

3.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

6.39

24.54

1.3

16.49

10.87

u/l

0.71

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

211

4.00

24.53

3.5

2.1

38.61

39.49

u/l

0.11

186

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

358

2292

2.48

24.28

4.5

2.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

167

4.33

24.11

1.6

2.4

0.02

0.03

g/l

0.11

154

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

105

5.23

23.89

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

123

4.84

23.41

1.3

1.2

12.80

8.28

u/ml

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

213

1093

2.51

23.39

2.7

1.7

1.71

1.17

mg/l

0.88

176

861

(3035350) Ketones [Presence] in Urine by Test strip

369

2419

2.46

23.38

7.2

4.1

0.00

estimate

0.50

127

480

(3012501) Base excess in Blood by calculation

104

5.17

23.14

6.4

3.9

2.77

2.63

mmol/l

0.12

(3021601) Nitrite [Presence] in Urine by Test strip

370

2437

2.45

23.07

9.3

5.3

0.00

estimate

-0.00

122

448

(3027801) Oxygen [Partial pressure] in Arterial blood

138

575

2.84

23.04

10.1

6.1

11.13

12.34

kpa

1.31

132

554

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

138

575

2.84

23.04

10.1

6.1

5.14

5.10

kpa

0.18

131

553

(3009261) Glucose [Presence] in Urine by Test strip

372

2466

2.44

22.70

7.3

4.0

0.00

0.01

estimate

0.50

124

440

(3003396) Base excess in Arterial blood by calculation

137

574

2.82

22.60

10.4

6.1

2.04

1.39

mmol/l

0.87

116

468

(3021589) Normoblasts [#/volume] in Blood

337

2143

2.38

22.57

32.0

9.9

0.00

e9/l

0.42

307

1760

(3021901) Oxygen saturation in Capillary blood

5.41

22.51

4.0

2.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

6.79

22.44

2.5

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

127

517

2.87

22.07

6.5

3.5

—

(3003181) Sodium [Moles/volume] in Urine

5.08

21.43

1.6

1.3

68.86

66.48

mmol/l

0.10

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

7.31

21.41

1.7

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

151

4.24

21.18

1.4

1.2

5.67

2.55

u/ml

0.58

(3000475) Leukocytes [#/volume] in Synovial fluid

125

4.57

21.12

2.2

1.7

30559.54

20849.19

e6/l

0.28

(3018677) aPTT in Platelet poor plasma by Coagulation assay

166

790

2.55

21.08

3.7

1.8

30.26

29.30

1.15

158

760

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

5.82

20.83

2.3

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

110

4.78

20.73

1.8

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

154

4.15

20.63

1.4

1.2

22.81

3.17

u/ml

1.00

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

127

535

2.76

20.57

6.0

2.7

13.49

8.37

umol/l

0.76

114

471

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

7.48

20.53

1.7

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

317

2022

2.26

20.29

8.0

3.8

35.65

52.67

ng/l

0.49

273

1484

(3019060) Gas panel - Arterial blood

344

3.11

20.24

5.9

4.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

157

4.07

20.10

1.5

2.4

0.00

g/l

-0.00

146

(3033658) Prothrombin time (PT) actual/Normal

224

1242

2.31

20.06

9.6

3.6

91.91

90.91

0.23

219

1204

(36660697) Celiac disease serology panel - Serum

364

3.04

19.97

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

159

4.02

19.75

1.5

2.4

0.00

g/l

-0.00

147

(3021788) Differential panel - Synovial fluid

4.90

19.72

1.8

1.7

—

(3017732) Neutrophils [#/volume] in Blood

332

3.11

19.69

5.0

2.8

4.81

5.63

e9/l

0.39

257

(3000991) Gas panel - Venous blood

107

423

2.88

19.47

15.5

6.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

6.98

19.30

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

6.98

19.30

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

6.98

19.30

1.3

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

162

3.94

19.24

1.4

1.1

—

(40758558) Short blood count panel - Blood

224

1267

2.26

18.89

15.7

6.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

102

4.70

18.80

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

102

4.70

18.80

1.5

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

103

4.65

18.58

3.2

2.2

122.45

127.84

g/l

0.68

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

7.41

18.37

1.1

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

7.52

17.94

1.1

1.2

0.09

2.04

u/ml

0.91

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

7.52

17.94

2.1

1.4

26.89

31.76

0.26

(3014576) Chloride [Moles/volume] in Serum or Plasma

135

624

2.52

17.92

14.0

6.0

102.86

104.03

mmol/l

1.78

135

624

(3004616) Nuclear Ab [Presence] in Serum

5.42

17.91

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

4.97

17.54

1.7

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

5.89

17.45

3.4

—

(3002032) Base excess in Venous blood by calculation

113

486

2.65

17.36

8.9

4.0

2.85

2.12

mmol/l

1.27

410

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

162

828

2.33

17.12

1.5

1.3

24.78

11.82

u/ml

0.99

292

(21494814) CD8 cells/100 lymphocytes in Specimen

22.70

16.98

1.8

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

220

3.31

16.69

2.5

2.2

10.32

13.02

nmol/l

1.94

194

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

321

2165

2.09

16.56

2.4

2.1

95.10

94.99

pmol/l

0.01

173

1041

(3048689) Calprotectin [Mass/mass] in Stool

124

575

2.47

16.21

4.6

2.4

193.08

131.70

ug/g

1.38

104

453

(3021447) Carbon dioxide [Partial pressure] in Venous blood

111

493

2.55

15.88

9.1

3.9

5.84

5.85

kpa

0.02

106

476

(3013512) EKG study

254

1589

2.07

15.88

6.4

3.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

216

1275

2.11

15.75

6.9

3.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

163

868

2.22

15.41

1.4

1.3

64.55

39.42

iu/ml

0.66

278

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

407

3056

2.13

15.08

6.9

3.0

79.39

47.55

u/l

2.28

384

2798

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

4.62

14.93

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

4.71

14.90

1.2

1.3

—

(3015736) pH of Urine

290

1941

2.00

14.66

5.8

3.8

5.90

—

130

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

4.75

14.65

1.2

1.3

296.28

306.17

u/ml

0.05

(3022145) Colonoscopy Study observation

123

597

2.35

14.40

1.6

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

6.38

14.30

1.2

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

244

1550

2.00

14.21

8.2

2.9

30.93

31.17

u/l

0.05

233

1472

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.61

14.20

2.2

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

4.85

14.16

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

16.28

14.02

4.9

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

5.30

13.76

1.3

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

139

3.59

13.73

3.6

3.2

—

(40768797) Stomach Pathology biopsy report

143

754

2.19

13.67

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

5.76

13.47

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

18.78

13.45

2.0

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

147

791

2.15

13.31

5.5

2.9

2.74

3.18

e6/l

0.26

418

(40761536) Microorganisms panel - Urine sediment

405

2.51

13.29

7.6

4.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

4.69

13.22

2.0

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

104

3.95

13.20

1.2

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

550

4819

4.13

13.07

57.0

14.8

22.73

23.29

mg/l

0.18

534

3813

(3000492) Spirometry study

409

2.49

13.00

2.1

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

4.62

12.99

2.1

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

4.62

12.99

2.1

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

217

1358

1.96

12.91

8.7

4.4

0.00

estimate

-0.00

119

440

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

6.14

12.68

1.5

1.1

—

(3044941) Cell count panel - Synovial fluid

4.19

12.55

1.5

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

4.53

12.30

2.1

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

4.53

12.30

5.7

1.8

32.13

32.06

0.03

(3025468) Yersinia sp identified in Specimen by Organism specific culture

4.53

12.30

2.1

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

4.47

12.08

2.1

1.3

—

(3000012) Reticulocyte production index

4.23

12.00

6.2

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.83

12.00

1.3

1.1

1.38

1.59

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

113

3.63

11.74

1.5

1.2

46.00

86.25

titre

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

174

1040

1.96

11.62

3.5

3.0

2.47

2.46

mmol/l

0.53

157

916

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

5.40

11.62

2.3

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

11.42

11.62

1.5

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

4.67

11.53

1.3

1.1

5.44

3.83

u/ml

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

4.98

11.53

2.3

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

4.98

11.53

2.3

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

151

864

2.01

11.40

5.4

2.7

0.91

1.17

e6/l

0.75

102

485

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

285

2.61

11.32

2.3

2.9

4.03

4.39

pmol/l

2.04

245

(3000093) Morphology [Interpretation] in Blood Narrative

4.73

11.29

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

13.05

11.21

3.3

6.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

20.52

11.18

2.1

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

127

3.40

11.17

1.5

1.3

—

555.00

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

9.48

11.09

1.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

9.48

11.09

1.4

1.7

—

(40768804) Tissue Pathology biopsy report

285

2021

1.81

10.98

2.7

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

345

2601

1.81

10.74

3.5

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

11.51

10.62

1.4

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

11.51

10.62

1.4

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

106

3.56

10.59

1.7

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

4.77

10.56

2.1

2.4

1.27

1.57

g/24h

0.20

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

10.87

10.34

1.4

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

4.68

10.33

3.5

2.2

—

(3017704) Immunofixation for Urine

7.68

10.27

1.3

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

449

2.22

10.04

3.9

2.3

36.34

30.77

u/l

0.59

369

(3025941) Bacteria identified in Stool by Culture

277

2.52

9.98

1.5

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

232

1583

1.78

9.89

4.0

3.1

5.86

6.83

mmol/l

2.95

204

1303

(3024891) Influenza virus A+B Ag [Presence] in Specimen

111

3.39

9.88

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

148

3.06

9.88

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

5.03

9.86

1.8

1.5

161828.50

352990.82

e6/l

0.30

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

7.58

9.78

2.2

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

264

1876

1.75

9.73

8.1

4.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

7.33

9.59

2.2

1.5

—

(40768443) Skin Pathology biopsy report

229

2.60

9.36

1.5

1.2

—

(3045414) Leukocytes [Presence] in Urine

217

2.64

9.34

1.9

—

(3008295) Osmolality of Serum or Plasma

4.17

9.33

1.3

1.4

269.67

276.78

mosm/kgh2o

0.78

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

179

1147

1.81

9.32

1.8

1.7

481.73

458.85

pmol/l

0.49

154

924

(3042111) Morphology [Interpretation] in Bone marrow Narrative

3.47

9.17

1.9

1.6

—

(4035726) Immunohistochemistry procedure

468

2.12

9.01

2.1

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

129

3.08

8.94

1.0

1.1

—

8.54

—

(3012441) Differential panel - Pleural fluid

4.78

8.88

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

6.77

8.73

1.3

233.33

128.00

titre

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

159

2.84

8.71

1.8

1.4

290.81

292.90

ug/g

0.03

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

155

969

1.82

8.66

7.4

4.1

636.92

309.07

ng/l

0.30

134

778

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

456

3859

1.87

8.51

5.2

4.1

15.31

14.97

pmol/l

1.96

420

3457

(3026389) Candida sp identified in Specimen by Organism specific culture

3.86

8.43

1.6

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

474

2.07

8.35

2.9

2.4

8.89

6.15

ug/l

0.44

408

(3024354) Oxygen [Partial pressure] in Venous blood

417

2.13

8.34

9.9

3.5

4.92

4.42

kpa

1.21

400

(3003434) Protein [Mass/volume] in Pleural fluid

4.20

8.33

1.5

1.2

25.75

31.99

g/l

1.11

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

6.64

8.25

1.4

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

247

2.40

7.98

16.1

7.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

4.54

7.95

1.6

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

6.24

7.91

3.7

1.4

0.87

1.02

g/l

1.04

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

6.24

7.91

2.7

2.4

—

(3045142) Bone marrow Pathology biopsy report

3.97

7.77

1.4

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

15.28

7.74

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

4.61

7.70

2.5

2.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

3.33

7.62

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

3.41

7.61

2.2

2.4

35.43

23.83

mg/l

—

(3028433) Virus identified in Specimen by Culture

9.03

7.58

1.1

—

(4200892) Spirometry reversibility

398

2.08

7.49

1.8

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

11.05

7.32

2.2

2.4

190.00

290.00

e6/l

—

(40768441) Liver Pathology biopsy report

4.24

7.32

2.6

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

3.22

7.23

1.5

1.3

—

(3004451) EKG impression Narrative

6.70

7.16

1.4

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.29

7.06

1.4

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

509

4550

2.02

6.92

6.4

5.0

1.86

2.23

mu/l

0.74

474

4095

(3024471) HLA-A [Type]

13.99

6.91

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

3.53

6.91

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

3.66

6.65

1.4

2.4

—

(3047181) Lactate [Moles/volume] in Blood

142

2.64

6.49

7.6

6.3

1.25

mmol/l

0.01

128

(3017569) Oxygen content in Arterial blood

6.39

6.20

1.9

1.6

—

(40768806) Pleura Pathology biopsy report

3.84

6.13

1.4

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

546

5056

2.53

6.12

54.6

17.3

138.77

139.69

mmol/l

9.79

539

4914

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

12.69

6.10

2.7

1.4

—

(3003129) Base excess in Capillary blood by calculation

8.73

6.08

2.1

1.1

1.52

2.16

mmol/l

0.13

(3023103) Potassium [Moles/volume] in Serum or Plasma

546

5066

2.49

5.91

54.9

17.5

3.95

3.98

mmol/l

1.41

539

4919

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

507

4585

1.88

5.79

43.6

14.1

74.85

76.65

ml/min/173m2

1.00

475

3764

(3028308) Erythrocytes [#/volume] in Pleural fluid

3.99

5.75

1.4

1.2

8260.00

61710.59

e6/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

140

2.52

5.64

2.9

3.2

0.93

0.88

nmol/l

0.16

108

(3024263) Appearance of Synovial fluid

5.95

5.56

2.4

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

10.15

5.55

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

10.15

5.55

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

591

1.75

5.47

3.2

3.9

4.55

17.51

ug/l

1.11

491

(3016650) Hepatitis A virus Ab [Presence] in Serum

3.09

5.43

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

16.20

5.42

1.0

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.71

5.40

2.4

2.2

—

(3024932) HLA-DR beta [Type]

11.40

5.30

1.0

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

9.23

5.30

1.8

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.10

5.28

1.0

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.10

5.28

1.0

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

3.12

5.27

1.5

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

5.29

5.11

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

220

2.13

5.08

2.5

2.9

568.09

937.70

u/ml

0.20

190

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

3.35

5.06

1.1

1.71

1.50

g/l

1.40

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

5.10

4.97

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.10

4.97

1.6

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.10

4.97

1.6

1.1

—

(40761511) CBC panel - Blood by Automated count

536

4984

2.09

4.95

44.8

14.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.57

4.79

1.8

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

549

5161

2.36

4.78

32.2

10.8

25.81

24.44

u/l

0.81

542

4950

(3020891) Body temperature

220

2.08

4.70

10.2

4.3

—

(3051611) Lipemic interference index of Serum or Plasma

3.40

4.63

5.3

2.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

4.60

4.58

1.4

1.1

1.91

1.90

mmol/l

0.00

(3048879) Bone marrow aspiration report

8.29

4.57

1.4

2.7

—

(21494434) Karyotype in Bone marrow

3.33

4.50

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

281

1.93

4.49

2.3

2.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

5.30

4.47

1.2

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

4.13

4.43

1.7

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

3.15

4.39

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

139

2.30

4.33

1.1

1.3

—

(3024928) Oxygen saturation in Venous blood

120

2.40

4.32

14.4

4.5

—

(40757373) Influenza virus identified in Isolate

8.99

4.29

2.0

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.99

4.29

1.1

101.50

106.00

—

(3011436) Histone Ab [Units/volume] in Serum

11.79

4.28

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.47

4.21

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

109

2.45

4.20

1.8

1.6

3.44

5.86

iu/l

—

(40768446) Kidney Pathology biopsy report

7.01

4.17

1.6

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

10.10

4.02

2.1

1.4

44.00

42.71

umol/l

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.31

3.93

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.31

3.93

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.31

3.93

1.2

—

(3014271) Vancomycin [Susceptibility]

3.85

3.91

3.5

2.5

—

(3045788) Cell count panel - Pleural fluid

3.85

3.91

1.5

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.85

3.91

1.7

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.85

3.91

1.7

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

7.36

3.87

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

7.36

3.87

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

2.65

3.84

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

108

2.37

3.81

3.9

3.7

182.55

3281.35

u/ml

0.74

103

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.24

3.80

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.24

3.80

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.24

3.80

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.65

3.76

1.7

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

4.65

3.76

5.5

15.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.65

3.76

1.3

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.65

3.76

1.7

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

327

0.32

3.73

1.5

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.65

3.72

1.9

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.74

3.68

1.1

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.46

3.64

2.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

4.83

3.57

1.0

1.1

713.80

110.64

iu/ml

—

(3034426) Prothrombin time (PT)

7.86

3.56

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

118

2.26

3.56

1.5

1.3

36.98

28.31

iu/l

0.41

(3002256) Pathology report gross observation

618

1.56

3.51

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

10.09

3.50

2.0

1.5

116.17

91.83

ng/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

100

695

1.53

3.48

4.3

4.7

35.69

32.81

1.66

438

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

226

0.30

3.38

1.3

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

5.06

3.38

5.3

3.9

54.44

51.83

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

2.88

3.38

1.5

1.3

378.80

284.04

pmol/l

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.78

3.35

1.3

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.78

3.35

1.3

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.78

3.35

1.3

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

5.78

3.35

1.3

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

686

1.52

3.30

1.4

1.5

—

(3047189) Immunofixation for 24 hour Urine

3.98

3.30

1.2

1.9

—

(40761535) Cells panel - Urine sediment

455

1.61

3.25

6.8

3.5

—

(3035880) pH of Pleural fluid

4.22

3.20

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

5.39

3.20

2.3

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

3.85

3.20

2.7

1.4

90.27

76.97

umol/l

0.31

(3010813) Leukocytes [#/volume] in Blood

553

5299

2.09

3.13

73.2

22.2

7.71

6.64

e9/l

17.54

544

5123

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

437

1.60

3.08

2.7

1.7

1.55

1.50

0.24

382

(3009466) Valproate [Moles/volume] in Serum or Plasma

2.63

3.07

3.4

4.9

280.45

385.07

umol/l

1.62

(3044290) Cell count panel - Cerebral spinal fluid

2.31

3.07

2.5

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

7.56

3.06

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

2.93

3.04

2.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.38

3.03

1.9

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

107

2.20

3.00

1.2

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.28

3.00

18.6

4.5

63.73

59.98

0.32

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

10.07

2.98

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

552

5296

2.02

2.95

73.8

22.2

37.54

39.71

11.81

514

4919

(3024731) MCV [Entitic volume]

552

5299

2.00

2.89

72.8

22.2

92.80

91.33

8.88

546

5203

(3035941) MCH [Entitic mass]

552

5299

2.00

2.89

72.7

22.1

30.30

0.01

546

5202

(3007461) Platelets [#/volume] in Blood

552

5299

2.00

2.89

73.3

22.2

260.86

250.42

e9/l

2.39

545

5144

(3000963) Hemoglobin [Mass/volume] in Blood

552

5300

2.00

2.87

73.8

22.3

124.25

133.24

g/l

35.90

547

5200

(3026361) Erythrocytes [#/volume] in Blood

552

5300

2.00

2.87

73.2

22.2

4.14

4.43

e12/l

29.01

545

5126

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

6.72

2.87

1.2

2.6

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

6.72

2.87

1.2

2.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

397

1.60

2.84

3.2

2.7

56.06

62.34

ml/min/173m2

0.50

173

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.49

2.80

1.0

1.1

11.76

9.43

ug/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

4.49

2.80

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.49

2.80

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.49

2.80

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

8.39

2.75

1.6

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

8.39

2.75

1.6

2.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.39

2.75

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.28

2.74

2.8

3.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.05

2.73

2.0

2.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

5.05

2.73

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.05

2.70

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

126

2.03

2.69

2.3

1.3

1529.96

518.03

mg/l

0.49

119

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.79

2.68

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.97

2.63

1.2

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

4.71

2.60

2.4

2.7

37630.86

39460.33

ug/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

7.19

2.55

1.2

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.50

2.55

1.0

1.3

—

(3051651) Icteric interference index of Serum or Plasma

3.26

2.53

6.2

2.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.26

2.53

1.4

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

490

4599

1.44

2.50

6.7

6.1

39.43

40.12

mmol/mol

0.97

443

4210

(3022621) pH of Urine by Test strip

329

1.60

2.48

6.4

2.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.85

2.47

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.85

2.47

1.1

—

(1002224) Polysomnography panel

176

0.33

2.44

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.37

2.40

1.7

1.4

—

(3018572) Chloride [Moles/volume] in Blood

104

2.06

2.39

10.1

6.5

105.05

104.99

mmol/l

0.02

(3039000) Anion gap in Blood

104

2.06

2.39

10.1

6.5

10.29

10.97

mmol/l

0.68

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.29

2.37

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.29

2.37

1.2

1.0

—

(40768795) Lymph node Pathology biopsy report

2.49

2.29

1.7

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

147

1179

1.33

2.28

7.4

4.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

2.23

0.0

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

3.14

2.23

1.0

321.22

297.33

mg/l

—

(3049717) Cytology report of Urine Cyto stain

188

1.74

2.22

2.4

2.7

—

(3012516) Albumin [Mass/volume] in Urine

184

1540

1.29

2.07

3.9

3.2

594.68

345.44

mg/l

0.30

125

929

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.03

2.04

1.0

1.3

57.67

72.07

nmol/24h

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

2.43

2.03

1.4

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

192

1619

1.28

2.03

4.5

3.8

28.85

6.65

mg/mmol

1.94

120

970

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.11

2.02

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

309

0.50

2.01

1.3

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

4.57

1.94

1.2

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.78

1.94

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

114

1.87

1.89

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.19

1.82

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

129

1562

0.78

1.78

3.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.53

1.67

1.5

1.4

—

53.33

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.18

1.66

1.0

1.1

1281.83

1653.53

miu/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

3.18

1.66

2.7

2.1

56.83

48.23

umol/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.60

1.66

1.3

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.27

1.64

2.0

2.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

189

0.47

1.64

1.2

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

132

0.37

1.64

1.2

1.5

—

(3011648) Oxygen content in Venous blood

2.40

1.62

1.9

7.9

11.39

10.53

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.59

1.62

2.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.59

1.62

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.52

1.60

1.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.00

1.55

2.6

2.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.35

1.52

1.4

1.1

—

(40765096) Chromosome analysis panel by Banding

3.35

1.52

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

312

1.44

1.46

1.2

27.27

136.36

iu/ml

6.77

124

(3051387) C reactive protein [Mass/volume] in Capillary blood

110

1.75

1.44

7.7

3.9

33.09

29.71

mg/l

0.20

(3003694) ABO and Rh group [Type] in Blood

138

1163

1.25

1.43

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

165

1.60

1.43

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.27

1.40

1.3

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

167

1.58

1.37

1.3

1.2

—

(3044889) 12 lead EKG panel

378

3528

1.21

1.36

5.8

4.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

1.35

0.0

1.0

—

278.81

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

1.35

0.0

1.0

—

39.30

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

1.35

0.0

1.0

—

627.91

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.06

1.33

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

169

1.56

1.31

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

2.11

1.30

1.2

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.37

1.29

2.0

1.2

9.52

6.06

ug/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

194

1.52

1.29

1.6

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.79

1.28

1.0

1.6

68.60

92.00

umol/l

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.79

1.28

4.4

2.7

—

(3000764) Benzodiazepines [Presence] in Urine

1.84

1.26

1.3

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.41

1.24

1.3

1.5

125.50

176.79

mmol/24h

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

498

4800

1.28

1.21

5.1

4.9

5.60

5.98

mmol/l

11.71

449

4325

(3027008) Opiates [Presence] in Urine

1.79

1.18

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.79

1.18

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

2.02

1.17

1.4

1.1

—

(3005570) Glucose [Moles/volume] in Urine

2.02

1.17

1.2

2.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.70

1.15

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.98

1.11

1.4

1.2

—

(3008898) HLA-B27 [Presence]

152

1.53

1.10

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

169

1.50

1.09

1.3

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.20

1.08

1.6

2.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.81

0.97

1.4

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

453

0.73

0.96

1.5

—

(3027944) Amphetamines [Presence] in Urine

1.70

0.96

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

1.78

0.95

3.9

1.5

—

(3011288) Drugs identified in Urine by Screen method

1.78

0.95

1.2

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

156

0.57

0.89

7.9

1.9

3.13

2.39

mg/l

—

122

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.80

0.88

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.73

0.86

2.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

114

1.51

0.80

1.6

—

(40768793) Breast Pathology biopsy report

163

0.61

0.79

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.83

0.79

7.3

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.77

0.76

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.86

0.68

1.2

1.9

—

(3019150) Specific gravity of Urine by Refractometry

123

1102

1.15

0.66

9.0

4.5

1.01

1.02

kg/l

1.43

145

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.62

0.65

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.73

0.64

1.8

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

492

4807

1.16

0.60

4.9

4.7

4.67

4.70

mmol/l

0.30

440

4378

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

237

1.28

0.59

1.1

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

488

4773

1.15

0.55

4.8

4.7

1.59

1.53

mmol/l

1.99

436

4322

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.50

0.53

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

1.50

0.53

1.3

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.52

0.53

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

268

0.78

0.50

1.9

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

470

4603

1.11

0.44

4.5

4.2

1.35

1.27

mmol/l

1.64

412

4135

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

114

1048

1.11

0.43

5.3

5.2

2.24

2.50

ug/l

0.15

932

(3000285) Sodium [Moles/volume] in Blood

0.00

0.41

0.0

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.2

—

2.13

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.43

0.39

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

157

0.76

0.36

1.7

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

243

0.82

0.34

1.8

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

838

0.91

0.32

4.1

4.6

20.42

21.04

0.11

411

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

499

4925

1.10

0.30

5.2

5.3

2.61

2.74

mmol/l

2.60

449

4466

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.22

0.27

1.0

1.2

0.70

0.62

nmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

141

1.21

0.26

5.6

4.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

235

1.16

0.25

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

137

0.80

0.24

1.5

1.1

—

(3025577) Chromium [Mass/volume] in Blood

1.32

0.23

2.6

2.2

2.62

2.31

ug/l

—

(4034850) Laboratory test

172

1.17

0.22

21.8

11.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.21

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.17

0.18

1.0

1.3

—

(3000330) Specific gravity of Urine by Test strip

257

1.09

0.13

4.6

3.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

611

0.94

0.13

2.6

3.0

0.49

0.76

ug/l

3.42

400

(3013139) Helicobacter pylori Ag [Presence] in Stool

326

1.08

0.12

1.1

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

696

0.96

0.10

12.2

7.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.80

0.08

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

139

1365

1.02

0.07

1.5

1.6

1.50

1.36

mmol/l

0.83

125

1136

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

130

1.08

0.04

2.6

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

765

1.02

0.04

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

125

0.96

0.00

2.4

325.80

89.65

ug/min

—

(3014051) Protein [Presence] in Urine by Test strip

128

1.02

0.00

4.0

2.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

0.99

0.00

1.5

1.4

0.97

0.88

nmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

299

1.00

0.00

1.2

1.4

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

1.73

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.4

—

6.92

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

0.92

-0.00

1.7

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.7

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.98

-0.00

1.0

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

25.82

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint OSTPOPATFRACTURE and mortality.

Females

Parameter	HR [95% CI]	p-value
OSTPOPATFRACTURE	2.879 [2.39, 3.46]	< 0.001
Birth year	0.996 [0.99, 1.01]	0.421

During the follow-up period (1.1.1998 — 31.12.2019), 572 out of 1455 females with OSTPOPATFRACTURE died.

Males

Parameter	HR [95% CI]	p-value
OSTPOPATFRACTURE	4.177 [3.06, 5.7]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.09

During the follow-up period (1.1.1998 — 31.12.2019), 329 out of 649 males with OSTPOPATFRACTURE died.

Mortality risk

Mortality risk for people of age

years, who have OSTPOPATFRACTURE.

N-year risk	Females	Males
1	0.297%	0.753%
5	1.672%	4.626%
10	3.99%	12.785%
15	7.552%	23.481%
20	14.115%	37.703%

Relationships between endpoints

↥

Index endpoint: OSTPOPATFRACTURE – Drug-induced osteoporosis with pathological fracture

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced osteoporosis with pathological fracture

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints